Investing Profile

Maina Bhaman

InvestorVC
Partner at Sofinnova Partners
Photo of Maina Bhaman, Partner at Soffinova Partners
cb
$100K - $5.0M
$1.5M
20
$548M
CompanyStageDateRound SizeTotal Raised
Purespring Therapeutics
Series BOct 2024$110M
$170M
Co-investors: Dominic Schmidt (Advent Life Sciences)
Myricx Bio
Series AJul 2024$120M
SeedNov 2020$6M
$120M
Co-investors: Stephen Thompson (Brandon Capital Partners), Jonathan Tobin (Brandon Capital Partners)
DISCO Pharmaceuticals
SeedJan 2024$22M
$22M
Co-investors: Therese Liechtenstein (M Ventures (Merck))
Mediar Therapeutics
Series AMar 2023$85M
$85M
Nuage Therapeutics
SeedMar 2023$13M
$13M
CinCor Pharma
Series BOct 2021$140M
Series AMay 2019$50M
$190M
Co-investors: James Healy (Sofinnova Investments), David Allison (Westlake Village BioPartners)
Catamaran Bio
Series ANov 2020$42M
$47M
Co-investors: Jack Kenney (SV Health Investors), Houman Ashrafian (SV Health Investors), Caroline Gaynor (Lightstone Ventures)
Sitryx Therapeutics
Series AOct 2018$30M
$30M
Co-investors: Houman Ashrafian (SV Health Investors)